Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Saturday, April 1, 2023.
Jounce Therapeutics, Inc. (NASDAQ:JNCE)
Long-Term Uptrend (+90) - JNCE is in a strong uptrend that is likely to continue. While JNCE is showing intraday weakness, it remains in the confines of a bullish trend. Traders should use caution and utilize a stop order.
Is it time to buy, sell, or avoid JNCE?
MarketClub looks at technical strength and momentum to determine if the timing is right for JNCE.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for JNCE
The long-term trend has been UP since Mar 15th, 2023 at 1.36
The intermediate-term trend has been UP since Mar 15th, 2023 at 1.36
The short-term trend has been UP since Mar 27th, 2023 at 1.60
Smart Scan Analysis for JNCE
Based on our trend formula, JNCE is rated as a +90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 1.850 | 1.860 | 1.840 | 1.845 | -0.005 |
| Prev. Close | Volume | Bid | Ask | Time |
| 1.850 | 916519 | 2023-03-31 15:59:17 |
| Year High | 29.25 | Year High Date | 2018-03-13 |
| Year Low | 3.3 | Year Low Date | 2018-11-14 |
| 52wk High | 7.94 | 52wk High Date | 2022-04-05 |
| 52wk Low | 0.5773 | 52wk Low Date | 2022-12-13 |
| Average Volume | 4,623,995 | Shares Outstanding | 52,140 |
| Market Cap | 123M | Assets | 212,550,000M |
| Liabilities | 29,438,000M | P/E Ratio | 11.1429 |
| Volatility | 99.75 |